DIN 02283859 — FLUDARABINE PHOSPHATE FOR INJECTION 25 MG
FLUDARABINE PHOSPHATE FOR INJECTION is a solution of Fludarabine marketed by TEVA CANADA LIMITED. The full Fludarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02283859
- Brand name
- FLUDARABINE PHOSPHATE FOR INJECTION
- Active ingredient
- Fludarabine
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Purine nucleoside analogue antineoplastic (antimetabolite chemotherapy agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fludarabine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02246226 | FLUDARA | 10 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02351722 | FLUDARABINE PHOSPHATE INJECTION | 25 MG | SOLUTION | FRESENIUS KABI CANADA LTD | DORMANT |
| 02438577 | FLUDARABINE PHOSPHATE INJECTION, USP | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |